GMDA
Price:
$0.0327
Market Cap:
$4.34M
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. In addition, the company is developing NK cell pipeline comprising GDA-301, GDA-401, GDA-501, and GDA-601 to trea...[Read more]
Industry
Biotechnology
IPO Date
2018-10-26
Stock Exchange
NASDAQ
Ticker
GMDA
According to Gamida Cell Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 0.35. This represents a change of -83.75% compared to the average of 2.17 of the last 4 quarters.
The mean historical Current Ratio of Gamida Cell Ltd. over the last ten years is 6.03. The current 0.35 Current Ratio has changed 484.09% with respect to the historical average. Over the past ten years (40 quarters), GMDA's Current Ratio was at its highest in in the September 2017 quarter at 21.31. The Current Ratio was at its lowest in in the March 2017 quarter at 0.
Average
6.03
Median
5.50
Minimum
2.16
Maximum
9.71
Discovering the peaks and valleys of Gamida Cell Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 21.19%
Maximum Annual Current Ratio = 9.71
Minimum Annual Increase = -46.35%
Minimum Annual Current Ratio = 2.16
Year | Current Ratio | Change |
---|---|---|
2023 | 2.16 | -19.09% |
2022 | 2.68 | -31.00% |
2021 | 3.88 | -35.71% |
2020 | 6.03 | 21.19% |
2019 | 4.98 | -46.35% |
2018 | 9.28 | -2.70% |
2017 | 9.53 | -1.86% |
The current Current Ratio of Gamida Cell Ltd. (GMDA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.91
5-year avg
3.94
10-year avg
6.03
Gamida Cell Ltd.’s Current Ratio is less than BioLineRx Ltd. (1.61), less than Ardelyx, Inc. (4.21), less than Lexicon Pharmaceuticals, Inc. (11.51), less than Seres Therapeutics, Inc. (1.38), less than ImmunityBio, Inc. (3.91), less than Protalix BioTherapeutics, Inc. (0), less than Iovance Biotherapeutics, Inc. (1.33), less than ImmunoGen, Inc. (5.15), less than X4 Pharmaceuticals, Inc. (5.47), less than Inozyme Pharma, Inc. (6.07), less than Terns Pharmaceuticals, Inc. (9.84), less than Day One Biopharmaceuticals, Inc. (21.02), less than HOOKIPA Pharma Inc. (4.09), less than null (3.86),
Company | Current Ratio | Market cap |
---|---|---|
1.61 | $55.61M | |
4.21 | $1.32B | |
11.51 | $582.00M | |
1.38 | $145.36M | |
3.91 | $2.35B | |
0 | $73.54M | |
1.33 | $3.04B | |
5.15 | $8.73B | |
5.47 | $109.78M | |
6.07 | $312.42M | |
9.84 | $549.60M | |
21.02 | $1.25B | |
4.09 | $159.50M | |
3.86 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gamida Cell Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gamida Cell Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Gamida Cell Ltd.'s Current Ratio?
How is the Current Ratio calculated for Gamida Cell Ltd. (GMDA)?
What is the highest Current Ratio for Gamida Cell Ltd. (GMDA)?
What is the 3-year average Current Ratio for Gamida Cell Ltd. (GMDA)?
What is the 5-year average Current Ratio for Gamida Cell Ltd. (GMDA)?
How does the current Current Ratio for Gamida Cell Ltd. (GMDA) compare to its historical average?